MedTrace Logo

Buffered Lidocaine in Paracervical Blocks

NCT03107754 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2021-01-05

Study results available
· View outcomes & findings →

Summary

For pain relief during a first trimester surgical aspiration, most providers use the paracervical block, either alone or in combination with other pain control techniques. Some providers use buffered lidocaine due to a belief that it decreases pain. Others use plain lidocaine. At our clinics, the standard pain management protocol is using 20 cc of 1% plain lidocaine in a two site injection. Few studies have compared buffered versus unbuffered lidocaine for paracervical blocks during first trimester uterine aspirations. This study seeks to determine if buffered lidocaine decreases injection pain versus plain lidocaine for paracervical blocks.

Conditions

Interventions

DRUG

Lidocaine

Paracervical block will be injected at 2 points at the cervicovaginal junction to decrease pain

DRUG

Lidocaine-Sodium Bicarbonate

Paracervical block will be injected at 2 points at the cervicovaginal junction to decrease pain

Sponsors & Collaborators

  • University of Hawaii

    lead OTHER

Principal Investigators

  • Principal Investigator · University of Hawaii

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2018-10-25
Completion
2018-10-25
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03107754 on ClinicalTrials.gov